Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biotique Systems Announces Fujisawa Pharmaceutical, Ono Pharmaceutical and Metabolex as New Customers for Its BLIS Genomic Integration System.


Business Editors/Health & Medical Writers

BIOWIRE2K

EMERYVILLE, Calif.--(BUSINESS WIRE)--Sept. 9, 2002

Biotique Systems, Inc. today announced that Fujisawa Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Metabolex, Inc. have joined the growing list of customers for the Biotique Local Integration System (BLIS BLIS Blind Spot Information System (Volvo)
BLIS Building Lifecycle Interoperable Software
BLIS Blood Information System
BLIS Base Level Inquiry System
BLIS Basic Load Inspection System
BLIS Bell Laboratories Interpretive System
) and extension products.

"We are delighted that our genome-based integration platform is gaining rapid recognition as a solution that meets the critical information management needs of both large and smaller biopharmaceutical companies," said Stephen Sanders, chairman and chief executive officer for Biotique Systems, Inc. "We are also pleased to expand our network of customers to include two of Japan's leading pharmaceutical companies, providing us with a strong entry into the Asia-Pacific market."

"BLIS allows us to easily integrate any annotation that we generate, from expressed sequence tags to microarray probes, onto a genomic reference template," said John Blume, Ph.D., vice president, strategic technologies for Metabolex, Inc. "As a result, we can securely visualize and analyze the information and begin to ask more intelligent and global questions of our data."

Fujisawa Pharmaceutical Co., Ltd., headquartered in Osaka Japan, is a research driven pharmaceutical company with global operations Global Operations is a first-person shooter computer game developed by Barking Dog Studios and published by both Crave Entertainment and Electronic Arts. It was released in March of 2002, following its public multiplayer beta version which contained only the Quebec map. . The company has net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
 of more than $2 billion and a work force of more than 8,000.

Ono Pharmaceutical Co., Ltd. is an R&D-oriented, international pharmaceutical company with an emphasis on applying genomics to creating innovative medicines in the areas of prostaglandins Prostaglandins
Prostaglandins are produced by the body and are responsible for inflammation features, such as swelling, pain, stiffness, redness and warmth.
, enzyme inhibitors, neuroscience and cellular signaling.

Metabolex, Inc., based in Hayward, California Hayward is a city located in the East Bay in Alameda County. The sixth largest city in the San Francisco Bay Area, it is one of the larger suburbs of Oakland. As of the 2000 census, the city population was 140,030. The estimated population in 2007 is 155,312. , is a privately held company privately held company

A firm whose shares are held within a relatively small circle of owners and are not traded publicly.
 founded to discover and develop therapeutics for diabetes. The company's lead product, MBX-102, is a novel insulin sensitizer sensitizer

see antigen.
 currently in Phase 1 clinical trials phase 1 clinical trial Phase 1 study. See Phase study. .

Biotique Systems, Inc. is a privately held company based in Emeryville, California founded in 2001 to solve critical issues in the life sciences. The company's core product, BLIS, is a data integration, analysis and visualization platform that enables pharmaceutical and biotechnology companies to expedite target discovery and refinement using the human genome as a reference template. Biotique's customers, which also include Bristol-Myers Squibb Company and Berlex Biosciences, Inc., are using BLIS to integrate disparate data for functional and comparative genomics, pharamcogenomics and other drug discovery research.

For more information, contact Biotique Systems, Inc. at 510/595-3110 or e-mail inquire@biotiquesystems.com or visit http://www.biotiquesystems.com.

Biotique Systems, BLIS and the Biotique logo are trademarks of Biotique Systems, Inc.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:9JAPA
Date:Sep 9, 2002
Words:397
Previous Article:Atomz Announces Enhancements to its Enterprise Web Site Management Software; Web-Native Software Model Enables Rapid Product Innovation Without...
Next Article:Silterra Promotes Joseph Dillon to VP of Logistics; Dillon to Manage Supply Chain Operations.
Topics:



Related Articles
QUARK SIGNS RESEARCH PACT WITH SHIONOGI.
VYSIS SHIPS GENOSENSOR MICROARRAY SYSTEM FOR GENOMIC RESEARCH.
ENHANCED WORKSPACE MANAGER INCLUDES PROPRIETY ANALYSIS TOOLS.
Ono Pharmaceutical Announces Changes in Investigational AIDS Drug Development Program.
Ono Pharmaceutical, Array BioPharma to Collaborate in Kinase-targeted Drug Discovery.
Astellas Establishes New Subsidiary 'Astellas Pharma Chemicals Co., Ltd.'.
Astellas Discontinues Development of Immunosuppressant FK778.
Banyu and Ono Begins Phase III Clinical Trials of a DPP-4 Inhibitor for Type 2 Diabetes Patients.
ASTELLAS' SCREENING TRIGGERS MILESTONE PAYMENT TO METABOLEX.
Ono Pharmaceutical Announces Establishment of Strategic Alliance Headquarters.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles